Progress in circulating tumor cell capture and analysis: Implications for cancer management

Marija Balic, Henry Lin, Anthony Williams, Ram H. Datar, Richard J. Cote

Research output: Contribution to journalReview article

37 Scopus citations

Abstract

The hematogenous dissemination of cancer and development of distant metastases is the cause of nearly all cancer deaths. Detection of circulating tumor cells (CTCs) as a surrogate biomarker of metastases has gained increasing interest. There is accumulating evidence on development of novel technologies for CTC detection, their prognostic relevance and their use in therapeutic response monitoring. Many clinical trials in the early and metastatic cancer setting, particularly in breast cancer, are including CTCs in their translational research programs and as secondary end points. We summarize the progress of detection methods in the context of their clinical importance and speculate on the possibilities of wider implementation of CTCs as a diagnostic oncology tool, the likelihood that CTCs will be used as a useful biomarker, especially to monitor therapeutic response, and what may be expected from the future improvements in technologies.

Original languageEnglish (US)
Pages (from-to)303-312
Number of pages10
JournalExpert Review of Molecular Diagnostics
Volume12
Issue number3
DOIs
StatePublished - Apr 1 2012

    Fingerprint

Keywords

  • cancer stem cells
  • characterization
  • circulating tumor cells
  • CTC
  • detection
  • DTC
  • enrichment
  • epithelial-mesenchymal transition
  • metastasis

ASJC Scopus subject areas

  • Molecular Medicine
  • Molecular Biology
  • Genetics
  • Pathology and Forensic Medicine

Cite this